Finnish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Medicines (Basel, Switzerland) 2017-Aug

Essential Oil of Cymbopogon citratus on the Control of the Curvularia Leaf Spot Disease on Maize.

Vain rekisteröityneet käyttäjät voivat kääntää artikkeleita
Kirjaudu sisään Rekisteröidy
Linkki tallennetaan leikepöydälle
Dalmarcia de Sousa Carlos Mourão
Talita Ferreira de Souza Pereira
Danival José de Souza
Aloísio Freitas Chagas Júnior
Mateus Sunti Dalcin
Ronice Alves Veloso
Evelynne Urzêdo Leão
Gil Rodrigues Dos Santos

Avainsanat

Abstrakti

The Curvularia Leaf Spot is becoming more common due to the culture expansion and the low resistance of the cultivated genotypes in tropical regions. Thus, the objective was to evaluate the fungitoxicity of the essential oil of Cymbopogon citratus upon the phytopathogen Curvularia lunata, causative agent of the Curvularia Leaf Spot. There was realized pathogenicity tests of C. lunata in maize plants, phytotoxicity of the essential oil of C. citratus and gas chromatography attached, germination tests of the conidia, and of in vitro inhibition of C. lunata. Also, there were realized tests aiming at verifying the phytopathogen control in vivo. In the pathogenicity tests, there were verified symptoms of the disease in all of the suspensions tested on plants. It was observed that the essential oil concentrations of 7.5 µL mL-1 to 50 µL mL-1 were phytotoxic. The majoritarian chemical components of the essential oil of C. citratus were Geranial (41.46%) and Neral (32.43%). The concentrations of 5 and 7.5 µL mL-1 inhibited 100% of conidia germination. None of the concentrations evaluated effectively inhibited C. lunata mycelial growth in in vitro tests. In the preventive control, the concentration of 7.5 µL mL-1 was sufficient for the reduction of the progress of the disease, however the curative control was not efficient on the tested dosages.

Liity facebook-sivullemme

Täydellisin lääketieteellinen tietokanta tieteen tukemana

  • Toimii 55 kielellä
  • Yrttilääkkeet tieteen tukemana
  • Yrttien tunnistaminen kuvan perusteella
  • Interaktiivinen GPS-kartta - merkitse yrtit sijaintiin (tulossa pian)
  • Lue hakuusi liittyviä tieteellisiä julkaisuja
  • Hae lääkekasveja niiden vaikutusten perusteella
  • Järjestä kiinnostuksesi ja pysy ajan tasalla uutisista, kliinisistä tutkimuksista ja patenteista

Kirjoita oire tai sairaus ja lue yrtteistä, jotka saattavat auttaa, kirjoita yrtti ja näe taudit ja oireet, joita vastaan sitä käytetään.
* Kaikki tiedot perustuvat julkaistuun tieteelliseen tutkimukseen

Google Play badgeApp Store badge